The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines

Biologicals

Volumn 37, Issue 2, 2009, Pages 119-126

  Kramer B ^a   Schildger, H ^a   Behrensdorf Nicol, H A ^a   Hanschmann, K M ^a   Duchow, K ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

Mouse challenge test; NIH test; Rabies vaccine; RFFIT; Serological assay

Indexed keywords

RABIES VACCINE;

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DRUG POTENCY; FEMALE; FLUORESCENCE ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SEROLOGY;

ANIMALS; ANTIBODY FORMATION; CELLS, CULTURED; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; MICE; NEUTRALIZATION TESTS; RABIES; RABIES VACCINES; SEROLOGIC TESTS; VACCINATION; VACCINES, INACTIVATED;

ANIMALIA; MUS;

EID: 63249116538     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2009.01.001     Document Type: Article

References (41)

1. WHO Expert Committee on rabies, 8th report. WHO technical report series 824 (1992), WHO, Geneva
2. Seligman E.B. The NIH test for potency. In: Kaplan M.M., and Koprowski H. (Eds). Laboratory techniques in rabies. 3rd ed. (1973), World Health Organization Publications, Geneva 279-286
3. Rabies vaccine for human use prepared in cell cultures. 6th ed. Monograph 0216. Ph Eur (2008), Council of Europe, Strasbourg, France
4. Rabies vaccine (inactivated) for veterinary use. 6th ed. Monograph 0451. Ph Eur (2008), Council of Europe, Strasbourg, France
5. Bruckner L., and Kihm U. Alternatives for potency testing of veterinary vaccines: rabies vaccine as a model. Dev Biol Stand 64 (1986) 93-97
6. Barth R., Diderrich G., and Weinmann E. NIH test, a problematic method for testing potency of inactivated rabies vaccine. Vaccine 6 (1988) 369-377
7. Eng T.R., Fishbein D.B., Talamante H.E., Fekadu M., Chavez G.F., Muro F.J., et al. Immunogenicity of rabies vaccines used during an urban epizootic of rabies in Mexico. Vaccine 12 (1994) 1259-1264
8. Perrin P., Morgeaux S., and Sureau P. In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody. Biologicals 18 (1990) 321-330
9. Lyng J., Bentzon M.W., Ferguson M., and Fitzgerald E.A. Rabies vaccine standardization: international collaborative study for the characterization of the fifth International standard for rabies vaccine. Biologicals 20 (1992) 301-313
10. Weißer K., and Hechler U. Animal welfare aspects in the quality control of immunobiologicals (1997), Frame, Nottingham
11. Ferguson M., Seagroatt V., and Schild G.C. A collaborative study on the use of single radial immunodiffusion for the assay of rabies virus glycoprotein. J Biol Stand 12 (1984) 283-294
12. Milne C., Daas A., Spieser J.M., and Bruckner L. Collaborative study for the establishment of rabies vaccine (inactivated) for veterinary use. European biological reference preparation batch no. 3. Pharmeuropa Bio 2 (2000) 57-64 [Special issue]
13. Daas A., and Milne C. Establishment of batch 4 of the biological reference preparation (BRP) for rabies vaccine (inactivated) for veterinary use. Pharmeuropa Bio 1 (2004) 17-22
14. Milne C. Report of the annual meeting 2007 of the CA/OMCLs involved in the control of immunological veterinary medicinal products in Prague (2007), European Directorate for the Quality of Medicines and Health Care, Strasbourg
15. Rooijakkers E., Groen J., Uittenbogaard J., van Herwijnen J., and Osterhaus A. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines. Dev Biol Stand 86 (1996) 137-145
16. Rooijakkers E.J.M., Uittenbogaard J.P., Groen J., and Osterhaus A.D.M.E. Rabies vaccine potency control: comparison of ELISA systems for antigenicity testing. J Virol Methods 58 (1996) 111-119
17. WHO Expert Committee on rabies, 7th report. WHO technical report series 709 (1984), WHO, Geneva
18. Fitzgerald E.A., Gallagher M., Hunter W.S., and Seligmann E.B. Use of the antibody assay in immunized mice for the determination of rabies vaccine potency. Dev Biol Stand 40 (1978) 183-186
19. Zalan E., Wilson C., and Pukitis D. A microtest for the quantitation of rabies virus neutralizing antibodies. J Biol Stand 7 (1979) 213-220
20. Human rabies immunoglobulin. 6th ed. Monograph 0723. Ph Eur (2008), Council of Europe, Strasbourg, France
21. Wunderli P.S., Shaddock J.H., Schmid D.S., Miller T.J., and Baer G.M. The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccines. Vaccine 9 (1991) 638-642
22. Diaz A.M.O., Miller R.A., Cortes M.A., Dellepiane N., Elberger D., Fabrega F., et al. Rabies reference vaccine for use as a regional standard for Latin America and the Caribbean countries. Biologicals 18 (1990) 281-287
23. Lyng J., Bentzon M.W., and Fitzgerald E.A. Potency assay of antibodies against rabies. A report on a collaborative study. J Biol Stand 17 (1989) 267-280
24. Lin L.I. A concordance correlation coefficient to evaluate reproducibility. Biometrics 45 (1989) 255-268
25. Wunderli P.S., Dreesen D.W., Miller T.J., and Baer G.M. Effects of vaccine route and dosage on protection from rabies after intracerebral challenge in mice. Am J Vet Res 64 (2003) 491-498
26. Baumans V., ten Berg R.G.M., Berkus A.P.M.G., Hackbarth H., and Timmerman A. Versuchsmethoden. In: van Zutphen L.F.M., Baumans V., and Beynen A.C. (Eds). Grundlagen der Versuchstierkunde (1995), Gustav Fischer Verlag, Stuttgart 269-285
27. Nicklas W., Cußler K., and Hartinger J. Tierschutzaspekte bei der Immunisierung von Versuchstieren. Merkblatt Nr. 4 (1997), Tierärztliche Vereinigung für Tierschutz e.V., Bonn
28. Haase M., Seinsche D., and Schneider W. The mouse neutralization test in comparison with the rapid fluorescent focus inhibition test: differences in the results in rabies antibody determinations. J Biol Stand 13 (1985) 123-128
29. Kurz J., Vogel I., Gerstl F., and Dostal V. Comparative studies of two potency tests for antirabies serum: neutralization test in mice (MNT) and rapid fluorescent focus inhibition test (RFFIT). Dev Biol Stand 64 (1986) 99-107
30. Smith J.S., Yager P.A., and Baer G.M. A rapid tissue culture test for determining rabies neutralizing antibody. In: Kaplan M.M., and Koprowski H. (Eds). Laboratory techniques in rabies (1973), WHO, Geneva 354-357
31. Russel W.M.S., and Burch R.L. The principles of humane experimental technique (1959), Methuen, London
32. Wunderli P.S., Dreesen D.W., Miller T.J., and Baer G.M. Effect of heterogeneity of rabies virus strain and challenge route on efficacy of inactivated rabies vaccines in mice. Am J Vet Res 64 (2003) 499-505
33. Baer G.M. Evaluation of an animal rabies vaccine by use of two types of potency tests. Am J Vet Res 58 (1997) 837-840
34. Hendriksen C.F.M. Opportunities for replacement, reduction or refinement: veterinary vaccines for mammals. In: Hendriksen C.F.M. (Ed). Laboratory animals in vaccine production and control (1988), Kluwer Academic Publishers, Dordrecht/Boston/London 125-139
35. Fournier-Caruana J., Poirier B., Haond G., Jallet C., Fuchs F., Tordo N., et al. Inactivated rabies vaccine control and release: use of an ELISA method. Biologicals 31 (2003) 9-16
36. Nagarajan T., Reddy G.S., Subramanian B.M., Rajalakshmi S., Thiagarajan D., Tordo N., et al. A simple immuno-capture ELISA to estimate rabies viral glycoprotein antigen in vaccine manufacture. Biologicals 34 (2006) 21-27
37. Ferguson M., and Heath A. Report of a collaborative study to assess the determination of glycoprotein antigen content of rabies vaccines for human use. Biologicals 20 (1992) 143-154
38. Gerstl F., and Vogel I. Is the NIH mouse potency test replaceable by the single radial immunodiffusion test. In: WHO (Ed). Progress in rabies control (1988), Wells Medical 311-314
39. Wunderli P.S., Dreesen D.W., Miller T.J., and Baer G.M. The rabies peripheral challenge test: more accurate determination of vaccine potency. Vaccine 24 (2006) 7115-7123
40. Barth R., Gruschkau H., Milcke L., Jaeger O., and Weinmann E. Validation of an in vitro assay for the determination of rabies antigen. Dev Biol Stand 64 (1986) 87-92
41. Feyssaguet M., Dacheux L., Audry L., Compoint A., Morize J.L., Blanchard I., et al. Multicenter comparative study of a new ELISA, PLATELIA™ RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vaccinated people. Vaccine 25 (2007) 2244-2251